One Biosciences Secures €15 Million to Enhance Single Cell Profiling in Oncology One Biosciences has successfully raised €15 million in Series A financing, aimed at enhancing its AI-driven single cell oncology platform, OneMap™, for better patient care.

One Biosciences Secures €15 Million to Enhance Single Cell Profiling in Oncology #Paris #France #healthcare #OneMap #One_Biosciences